H. Hamidou

633 total citations
20 papers, 470 citations indexed

About

H. Hamidou is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, H. Hamidou has authored 20 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in H. Hamidou's work include Esophageal Cancer Research and Treatment (7 papers), Gastric Cancer Management and Outcomes (7 papers) and Esophageal and GI Pathology (4 papers). H. Hamidou is often cited by papers focused on Esophageal Cancer Research and Treatment (7 papers), Gastric Cancer Management and Outcomes (7 papers) and Esophageal and GI Pathology (4 papers). H. Hamidou collaborates with scholars based in France, Luxembourg and Benin. H. Hamidou's co-authors include Pierre Michel, B Paillot, David Tougeron, Frédéric Di Fiore, Olivier Rigal, F. Di Fiore, Stéphane Lecleire, Éric Lerebours, Philippe Ducrotté and Daniela Pop and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

H. Hamidou

20 papers receiving 455 citations

Peers

H. Hamidou
Mustafa Duman Türkiye
Kenjiro Ishii Japan
F. Meister Germany
Rimantas Baušys Lithuania
Chi Hyuk Oh South Korea
Eiji Tsubouchi Japan
Kasım Çağlayan Türkiye
Hiroka Yamago Japan
Eishin Hoshi Japan
Francesco Vito Mandarino Italy
Mustafa Duman Türkiye
H. Hamidou
Citations per year, relative to H. Hamidou H. Hamidou (= 1×) peers Mustafa Duman

Countries citing papers authored by H. Hamidou

Since Specialization
Citations

This map shows the geographic impact of H. Hamidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Hamidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Hamidou more than expected).

Fields of papers citing papers by H. Hamidou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Hamidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Hamidou. The network helps show where H. Hamidou may publish in the future.

Co-authorship network of co-authors of H. Hamidou

This figure shows the co-authorship network connecting the top 25 collaborators of H. Hamidou. A scholar is included among the top collaborators of H. Hamidou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Hamidou. H. Hamidou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guérif, S., Florence Castan, E. Meyer, et al.. (2023). OC-0433 GETUG-AFU 22 phase II randomized trial : final results on clinical outcomes with immediate SRT. Radiotherapy and Oncology. 182. S334–S334. 1 indexed citations
2.
Ferrer, Ludovic, Olivier Morel, Daniéla Rusu, et al.. (2020). Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer. Cancers. 12(6). 1512–1512. 5 indexed citations
3.
4.
Latorzeff, I., S. Guérif, Julien Fraisse, et al.. (2019). Late Toxicity and Quality of Life from GETUG-AFU 22 Study: A Multicenter Randomized Phase II Trial Comparing Radiotherapy +/- 6 Months of Degarelix as a Salvage Treatment for Patients with Detectable PSA after Radical Prostatectomy. International Journal of Radiation Oncology*Biology*Physics. 105(1). S134–S134. 1 indexed citations
5.
6.
Campion, L., G. Delpon, F. Thillays, et al.. (2016). High-Dose Hypofractionated Radiation Therapy for Noncompressive Vertebral Metastases in Combination With Zoledronate: A Phase 1 Study. International Journal of Radiation Oncology*Biology*Physics. 96(4). 840–847. 16 indexed citations
7.
Choussy, Olivier, et al.. (2011). Basaloid squamous cell carcinoma of the head and neck: report of 18 cases. The Journal of Laryngology & Otology. 125(6). 608–613. 6 indexed citations
8.
Tougeron, David, Michel Scotté, H. Hamidou, et al.. (2011). Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: An alternative to surgery?. Journal of Surgical Oncology. 105(8). 761–766. 11 indexed citations
9.
Tougeron, David, Bernard Roullet, B Paillot, et al.. (2011). Safety and outcome of chemoradiotherapy in elderly patients with rectal cancer: Results from two French tertiary centres. Digestive and Liver Disease. 44(4). 350–354. 26 indexed citations
10.
Tougeron, David, H. Hamidou, Michel Scotté, et al.. (2010). Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes. BMC Cancer. 10(1). 510–510. 35 indexed citations
11.
12.
Tougeron, David, H. Hamidou, F. Dujardin, et al.. (2009). Unusual skeletal muscle metastasis from gastric adenocarcinoma. Gastroentérologie Clinique et Biologique. 33(6-7). 485–487. 12 indexed citations
13.
Tougeron, David, F. Di Fiore, B. Lefébure, et al.. (2009). Control of pelvic symptoms in patients with rectal cancer and synchronous metastases. Gastroentérologie Clinique et Biologique. 33(12). 1106–1113. 4 indexed citations
14.
Tougeron, David, F. Di Fiore, S. Thureau, et al.. (2008). Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. British Journal of Cancer. 99(10). 1586–1592. 95 indexed citations
15.
Tougeron, David, Zeina Nasser, B. Lefébure, et al.. (2008). Unusual iris metastasis from anal cancer: A case report. Digestive and Liver Disease. 41(7). e1–e3. 5 indexed citations
16.
Fiore, Frédéric Di, Stéphane Lecleire, Daniela Pop, et al.. (2007). Baseline Nutritional Status Is Predictive of Response to Treatment and Survival in Patients Treated by Definitive Chemoradiotherapy for a Locally Advanced Esophageal Cancer. The American Journal of Gastroenterology. 102(11). 2557–2563. 142 indexed citations
17.
Tougeron, David, Frédéric Di Fiore, H. Hamidou, et al.. (2007). Response to Definitive Chemoradiotherapy and Survival in Patients with an Oesophageal Adenocarcinoma versus Squamous Cell Carcinoma: A Matched-Pair Analysis. Oncology. 73(5-6). 328–334. 17 indexed citations
18.
Michel, Pierre, Antoine Adenis, F. Di Fiore, et al.. (2006). Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial. British Journal of Cancer. 95(6). 705–709. 38 indexed citations
19.
Fiore, Frédéric Di, Stéphane Lecleire, Marie‐Pierre Galais, et al.. (2006). Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer. Gastroentérologie Clinique et Biologique. 30(6-7). 845–851. 11 indexed citations
20.
Dujardin, F., Marc Debled, Cécile Guillemet, et al.. (2006). Prise en charge des tumeurs des parties molles de l’appareil locomoteur de l’adulte. Revue de Chirurgie Orthopédique et Réparatrice de l Appareil Moteur. 92(7). 637–650. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mustafa Duman Breakdown of academic impact, for papers by Kenjiro Ishii Breakdown of academic impact, for papers by F. Meister Breakdown of academic impact, for papers by Rimantas Baušys Breakdown of academic impact, for papers by Chi Hyuk Oh Breakdown of academic impact, for papers by Eiji Tsubouchi Breakdown of academic impact, for papers by Kasım Çağlayan Breakdown of academic impact, for papers by Hiroka Yamago Breakdown of academic impact, for papers by Eishin Hoshi Breakdown of academic impact, for papers by Francesco Vito Mandarino
Rankless by CCL
2026